DermTech (DMTK)
(Delayed Data from NSDQ)
$0.60 USD
+0.02 (3.02%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.60 0.00 (-0.51%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for DermTech, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 15 | 15 | 12 | 6 | 3 |
Cost Of Goods | 15 | 14 | 11 | 6 | 3 |
Gross Profit | 0 | 1 | 1 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 104 | 119 | 79 | 35 | 18 |
Income After Depreciation & Amortization | -104 | -118 | -77 | -35 | -18 |
Non-Operating Income | 3 | 1 | -1 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 3 |
Pretax Income | -101 | -117 | -78 | -35 | -20 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -101 | -117 | -78 | -35 | -20 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -101 | -117 | -78 | -35 | -20 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -98 | -113 | -74 | -35 | -16 |
Depreciation & Amortization (Cash Flow) | 5 | 5 | 3 | 0 | 2 |
Income After Depreciation & Amortization | -104 | -118 | -77 | -35 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 32.64 | 30.04 | 28.89 | 16.98 | 7.01 |
Diluted EPS Before Non-Recurring Items | -3.09 | -3.88 | -2.71 | -2.08 | -2.81 |
Diluted Net EPS (GAAP) | -3.09 | -3.88 | -2.71 | -2.08 | -2.81 |
Fiscal Year end for DermTech, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 3.92 | 3.92 | 3.98 | 3.48 |
Cost Of Goods | NA | 3.48 | 3.74 | 3.97 | 3.82 |
Gross Profit | NA | 0.44 | 0.17 | 0.01 | -0.34 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 20.19 | 19.99 | 32.14 | 31.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -19.75 | -19.82 | -32.13 | -32.04 |
Non-Operating Income | NA | 0.66 | 0.65 | 0.77 | 0.78 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -19.09 | -19.16 | -31.36 | -31.27 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -19.09 | -19.16 | -31.36 | -31.27 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -19.09 | -19.16 | -31.36 | -31.27 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 34.33 | 33.84 | 31.79 | 30.56 |
Diluted EPS Before Non-Recurring Items | NA | -0.56 | -0.57 | -0.99 | -1.02 |
Diluted Net EPS (GAAP) | NA | -0.51 | -0.57 | -0.99 | -1.02 |